Analysts Set Expectations for Ayr Wellness FY2024 Earnings

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Stock analysts at Roth Capital dropped their FY2024 earnings per share estimates for shares of Ayr Wellness in a research report issued to clients and investors on Wednesday, November 13th. Roth Capital analyst W. Kirk now forecasts that the company will post earnings per share of ($1.40) for the year, down from their previous estimate of ($1.22). Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.30) per share. Roth Capital also issued estimates for Ayr Wellness’ Q4 2024 earnings at ($0.34) EPS, Q1 2025 earnings at ($0.32) EPS, Q2 2025 earnings at ($0.31) EPS, Q3 2025 earnings at ($0.30) EPS, Q4 2025 earnings at ($0.30) EPS and FY2025 earnings at ($1.23) EPS.

Other equities research analysts have also issued reports about the stock. Roth Mkm reduced their price objective on shares of Ayr Wellness from $3.50 to $3.00 and set a “buy” rating on the stock in a report on Thursday, November 14th. Atb Cap Markets downgraded Ayr Wellness from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 13th.

Ayr Wellness Price Performance

Shares of Ayr Wellness stock opened at $0.77 on Monday. The company has a quick ratio of 0.67, a current ratio of 1.59 and a debt-to-equity ratio of 0.76. Ayr Wellness has a 52-week low of $0.71 and a 52-week high of $4.09. The company has a market capitalization of $87.90 million, a P/E ratio of -0.35 and a beta of 2.00. The company has a 50 day moving average of $1.79 and a 200 day moving average of $1.97.

Ayr Wellness Company Profile

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.